Herpes Zoster in the Long-Term Care Setting

Published

Journal Article (Review)

This article reviews the epidemiology, clinical features, diagnosis, infection control, and treatment of herpes zoster (HZ) with special reference to the long-term care facility. HZ is caused by the reactivation of varicella-zoster virus (VZV) in sensory ganglia in the setting of age-, disease-, and drug-related decline in cellular immunity to VZV. HZ afflicts millions of older adults worldwide annually and causes substantial suffering via acute and chronic pain or postherpetic neuralgia. In the long-term care facility, VZV may be transmitted to seronegative, susceptible individuals and cause varicella. The use of varicella-zoster immune globulin (VZIG) and the varicella vaccine for susceptible individuals is discussed.

Duke Authors

Cited Authors

  • Schmader, K

Published Date

  • January 1, 2004

Published In

Volume / Issue

  • 12 / 1

Start / End Page

  • 38 - 42

International Standard Serial Number (ISSN)

  • 1524-7929

Citation Source

  • Scopus